Frontlight ResearchEarly access
Trial site
ICON Cancer Centre - Southport
- 7running trials
- 1closed trial
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Endometrial cancer2 trials
- Gastric and oesophageal cancer2 trials
- Metastatic breast cancer2 trials
- Prostate cancer2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Colorectal cancer1 trial
- Liver and biliary tract cancer1 trial
- Ovarian cancer1 trial
- Pancreatic cancer1 trial
- Sarcoma1 trial
- Phase
- Phase 36 trials
- Phase 21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting4 trials
- Recruiting2 trials
- Completed1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Celcuity Inc2 trials
- Pfizer2 trials
- ALX Oncology Inc.1 trial
- Bayer1 trial
- Karyopharm Therapeutics Inc1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Sarcoma1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026